This section includes information and resources about Stroke Prevention in Atrial Fibrillation (AF) for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos. For additional information please visit NEWSCENTRE.
ESC launches new concept for driving innovation in cardiovascular research with exclusive support from Boehringer Ingelheim
MHRA review confirms benefit/risk profile of Alteplase - the only licensed clot buster for acute ischaemic stroke
Idarucizumab* reverses the anticoagulant effect of dabigatran within minutes in patient study
New publication in The Lancet describes effective reversal of Pradaxa® in healthy volunteers
First patient enrolled in dabigatran study comparing anticoagulation strategies during AF ablation